Anti-Müllerian hormone levels and spontaneous pregnancy in women undergoing surgery for benign ovarian cysts

Gynecol Endocrinol. 2018 Oct;34(10):909-912. doi: 10.1080/09513590.2018.1465548. Epub 2018 May 4.

Abstract

This prospective study had the objective to compare anti-Müllerian hormone (AMH) serum levels among women with endometriomas and those with other benign ovarian cysts and verify a possible correlation between the AMH post-operative decline and the achievement of pregnancy. The study included 57 women undergoing laparoscopic surgery. Serum levels of AMH were measured preoperatively and at 6 and 12 months postoperatively. AMH serum levels decreased in both endometriomas and other benign cysts, but significant recovery was reported only in endometriomas (p = .029). Through an interview, information on reproductive outcome was obtained. The secondary endpoint was to identify other predictors of spontaneous pregnancy onset. After surgery 27 women attempted to conceive. At 18-months follow-up, 12 of them got pregnant, with a live birth of 37%. We did not record statistically significant differences in reproductive outcome between women with AMH serum levels lower and higher than 1.1 ng/ml (41.7 and 53.3% respectively). There was no statistically significant difference in AMH serum levels between pregnant and non-pregnant women, neither before nor after surgery. AMH did not appear to have a predictive role on reproductive outcome.

Keywords: Anti-Müllerian hormone; benign ovarian cysts; laparoscopic surgery; spontaneous pregnancy.

MeSH terms

  • Adolescent
  • Adult
  • Anti-Mullerian Hormone / blood*
  • Female
  • Humans
  • Laparoscopy
  • Ovarian Cysts / blood
  • Ovarian Cysts / surgery*
  • Pregnancy
  • Prospective Studies
  • Young Adult

Substances

  • Anti-Mullerian Hormone